126 related articles for article (PubMed ID: 35039097)
1. Dissection of depression heterogeneity using proteomic clusters.
van Haeringen M; Milaneschi Y; Lamers F; Penninx BWJH; Jansen R
Psychol Med; 2023 May; 53(7):2904-2912. PubMed ID: 35039097
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.
Kim K; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Kim H; Na EJ; Yu HY; Jeon HJ
Compr Psychiatry; 2019 Nov; 95():152140. PubMed ID: 31669792
[TBL] [Abstract][Full Text] [Related]
3. Polygenic dissection of major depression clinical heterogeneity.
Milaneschi Y; Lamers F; Peyrot WJ; Abdellaoui A; Willemsen G; Hottenga JJ; Jansen R; Mbarek H; Dehghan A; Lu C; ; Boomsma DI; Penninx BW
Mol Psychiatry; 2016 Apr; 21(4):516-22. PubMed ID: 26122587
[TBL] [Abstract][Full Text] [Related]
4. Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study.
Corponi F; Anmella G; Verdolini N; Pacchiarotti I; Samalin L; Popovic D; Azorin JM; Angst J; Bowden CL; Mosolov S; Young AH; Perugi G; Vieta E; Murru A
Eur Neuropsychopharmacol; 2020 Jun; 35():49-60. PubMed ID: 32409261
[TBL] [Abstract][Full Text] [Related]
5. Leptin Dysregulation Is Specifically Associated With Major Depression With Atypical Features: Evidence for a Mechanism Connecting Obesity and Depression.
Milaneschi Y; Lamers F; Bot M; Drent ML; Penninx BW
Biol Psychiatry; 2017 May; 81(9):807-814. PubMed ID: 26742925
[TBL] [Abstract][Full Text] [Related]
6. Serum proteomic profiling of major depressive disorder.
Bot M; Chan MK; Jansen R; Lamers F; Vogelzangs N; Steiner J; Leweke FM; Rothermundt M; Cooper J; Bahn S; Penninx BW
Transl Psychiatry; 2015 Jul; 5(7):e599. PubMed ID: 26171980
[TBL] [Abstract][Full Text] [Related]
7. Youth depression and inflammation: Cross-sectional network analyses of C-Reactive protein, interleukin-6 and symptoms in a population-based sample.
Manfro PH; Anselmi L; Barros F; Gonçalves H; Murray J; Oliveira IO; Tovo-Rodrigues L; Wehrmeister FC; Menezes AMB; Mondelli V; Rohde LA; Kieling C
J Psychiatr Res; 2022 Jun; 150():197-201. PubMed ID: 35395610
[TBL] [Abstract][Full Text] [Related]
8. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study.
Lamers F; Milaneschi Y; Vinkers CH; Schoevers RA; Giltay EJ; Penninx BWJH
Brain Behav Immun; 2020 Aug; 88():174-183. PubMed ID: 32272220
[TBL] [Abstract][Full Text] [Related]
9. Serum proteomic profiles of depressive subtypes.
Lamers F; Bot M; Jansen R; Chan MK; Cooper JD; Bahn S; Penninx BW
Transl Psychiatry; 2016 Jul; 6(7):e851. PubMed ID: 27404283
[TBL] [Abstract][Full Text] [Related]
10. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).
van Reedt Dortland AK; Giltay EJ; van Veen T; van Pelt J; Zitman FG; Penninx BW
J Clin Psychiatry; 2010 Jun; 71(6):729-36. PubMed ID: 20021996
[TBL] [Abstract][Full Text] [Related]
11. Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study.
Kappelmann N; Czamara D; Rost N; Moser S; Schmoll V; Trastulla L; Stochl J; Lucae S; ; Binder EB; Khandaker GM; Arloth J
Brain Behav Immun; 2021 Jul; 95():256-268. PubMed ID: 33794315
[TBL] [Abstract][Full Text] [Related]
12. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.
Akkasheh G; Kashani-Poor Z; Tajabadi-Ebrahimi M; Jafari P; Akbari H; Taghizadeh M; Memarzadeh MR; Asemi Z; Esmaillzadeh A
Nutrition; 2016 Mar; 32(3):315-20. PubMed ID: 26706022
[TBL] [Abstract][Full Text] [Related]
13. The impact of somatic symptoms on the course of major depressive disorder.
Bekhuis E; Boschloo L; Rosmalen JG; de Boer MK; Schoevers RA
J Affect Disord; 2016 Nov; 205():112-118. PubMed ID: 27428090
[TBL] [Abstract][Full Text] [Related]
14. Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates.
Fried EI; von Stockert S; Haslbeck JMB; Lamers F; Schoevers RA; Penninx BWJH
Psychol Med; 2020 Dec; 50(16):2682-2690. PubMed ID: 31615595
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
Ramsey JM; Cooper JD; Bot M; Guest PC; Lamers F; Weickert CS; Penninx BW; Bahn S
PLoS One; 2016; 11(5):e0156624. PubMed ID: 27232630
[TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
18. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
19. Associations between individual depressive symptoms and immunometabolic characteristics in major depression.
Chae WR; Baumert J; Nübel J; Brasanac J; Gold SM; Hapke U; Otte C
Eur Neuropsychopharmacol; 2023 Jun; 71():25-40. PubMed ID: 36966710
[TBL] [Abstract][Full Text] [Related]
20. Developing symptom clusters: linking inflammatory biomarkers to depressive symptom profiles.
Franklyn SI; Stewart J; Beaurepaire C; Thaw E; McQuaid RJ
Transl Psychiatry; 2022 Mar; 12(1):133. PubMed ID: 35361785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
